Journal Publications
| No. | Author | Title | Journal Name | Year/Month |
|---|---|---|---|---|
| 1277 | Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, Gift S, Grande R, Bryson M, Lee A, Dussupt V, Mendez-Riveria L, Sanders-Buell E, Chenine AL, Tran U, Li Y, Brown E, Edlefsen PT, O'Connell R, Gilbert P, Nitayaphan S, Pitisuttihum P, Rerks-Ngarm S, Robb ML, Gramzinski R, Alter G, Tovanabutra S, Georgiev IS, Ackerman ME, Polonis VR, Vasan S, Michael NL, Kim JH, Eller MA, Krebs SJ, Rolland M | RV144 HIV-1 vaccination impacts post-infection antibody responses. | PLoS Pathog | 01/2021 |
| 1276 | Kroon EDMB, Ananworanich J, Pagliuzza A, Rhodes A, Phanuphak N, Trautmann L, Mitchell JL, Chintanaphol M, Intasan J, Pinyakorn S, Benjapornpong K, Chang JJ, Colby DJ, Chomchey N, Fletcher JLK, Eubanks K, Yang H, Kapson J, Dantanarayana A, Tennakoon S, Gorelick RJ, Maldarelli F, Robb ML, Kim JH, Spudich S, Chomont N, Phanuphak P, Lewin SR, de Souza MS | A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection. | J Virus Erad | 01/2021 |
| 1275 | Easterhoff D, Pollara J, Luo K, Janus B, Gohain N, Williams LD, Tay MZ, Monroe A, Peachman K, Choe M, Min S, Lusso P, Zhang P, Go EP, Desaire H, Bonsignori M, Hwang KK, Beck C, Kakalis M, O'Connell RJ, Vasan S, Kim JH, Michael NL, Excler JL, Robb ML, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J, Phogat S, Wiehe K, Saunders KO, Montefiori DC, Tomaras GD, Moody MA, Arthos J, Rao M, Joyce MG, Ofek G, Ferrari G, Haynes BF | HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. | JCI Insight | 01/2021 |
| 1274 | Yoon IK, Srikiatkhachorn A, Alera MT, Fernandez S, Cummings DAT, Salje H | Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort. | Int J Infect Dis | 01/2021 |
| 1273 | Cavalcante JR, Abreu AJL | COVID-19 in the city of Rio de Janeiro: spatial analysis of first confirmed cases and deaths. | Epidemiol Serv Saude | 01/2021 |
| 1272 | Krumkamp R, Struck NS, Lorenz E, Zimmermann M, Boahen KG, Sarpong N, Owusu-Dabo E, Pak GD, Jeon HJ, Marks F, Jacobs T, May J, Eibach D | Classification of invasive bloodstream infections and Plasmodium falciparum malaria using autoantibodies as biomarkers. | Sci Rep | 01/2021 |
| 1271 | Choi JA, Goo J, Yang E, Jung DI, Lee S, Rho S, Jeong Y, Park YS, Park H, Moon YH, Park U, Seo SH, Lee H, Lee JM, Cho NH, Song M, Kim JO | Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein. | J Virol | 01/2021 |
| 1270 | Kim JH | SARS-CoV-2 vaccine development, access, and equity. | J Exp Med | 01/2021 |
| 1269 | Manandhar S, Zellweger RM, Maharjan N, Dongol S, Prajapati KG, Thwaites G, Basnyat B, Dixit SM, Baker S, Karkey A | A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes. | Ann Clin Microbiol Antimicrob | 01/2021 |
| 1268 | Volkmann A, Williamson AL, Weidenthaler H, Meyer TPH, Robertson JS, Excler JL, Condit RC, Evans E, Smith ER, Kim D, Chen RT | The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. | Vaccine | 01/2021 |
| 1267 | Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S | Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. | Vaccine | 01/2021 |
| 1266 | Kim JS, Choi JA, Kim JC, Park H, Yang E, Park JS, Song M, Park JH | Microneedles with dual release pattern for improved immunological efficacy of Hepatitis B vaccine. | Int J Pharm | 01/2021 |
| 1265 | Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS | A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report. | BMC Pediatr | 01/2021 |
| 1264 | Im J, Islam MT, Ahmmed F, Kim DR, Khan AI, Zaman K, Ali M, Marks F, Qadri F, Kim J, Clemens JD | Can existing improvements of water, sanitation, and hygiene (WASH) in urban slums reduce the burden of typhoid fever in these settings? | Clin Infect Dis | 01/2021 |
| 1263 | Capeding MR, Sil A, Tadesse BT, Saluja T, Teshome S, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ryu JH, Cheong I, Shim KY, Lee Y, Kim H, Lynch JA, Kim JH, Excler JL, Wartel TA, Sahastrabuddhe S | Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study. | EClinicalMedicine | 01/2021 |
| No.1277 | Author | Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, Gift S, Grande R, Bryson M, Lee A, Dussupt V, Mendez-Riveria L, Sanders-Buell E, Chenine AL, Tran U, Li Y, Brown E, Edlefsen PT, O'Connell R, Gilbert P, Nitayaphan S, Pitisuttihum P, Rerks-Ngarm S, Robb ML, Gramzinski R, Alter G, Tovanabutra S, Georgiev IS, Ackerman ME, Polonis VR, Vasan S, Michael NL, Kim JH, Eller MA, Krebs SJ, Rolland M |
| Title | RV144 HIV-1 vaccination impacts post-infection antibody responses. | |
| Journal Name | PLoS Pathog | |
| Month / Year | 01/2021 | |
| No.1276 | Author | Kroon EDMB, Ananworanich J, Pagliuzza A, Rhodes A, Phanuphak N, Trautmann L, Mitchell JL, Chintanaphol M, Intasan J, Pinyakorn S, Benjapornpong K, Chang JJ, Colby DJ, Chomchey N, Fletcher JLK, Eubanks K, Yang H, Kapson J, Dantanarayana A, Tennakoon S, Gorelick RJ, Maldarelli F, Robb ML, Kim JH, Spudich S, Chomont N, Phanuphak P, Lewin SR, de Souza MS |
| Title | A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection. | |
| Journal Name | J Virus Erad | |
| Month / Year | 01/2021 | |
| No.1275 | Author | Easterhoff D, Pollara J, Luo K, Janus B, Gohain N, Williams LD, Tay MZ, Monroe A, Peachman K, Choe M, Min S, Lusso P, Zhang P, Go EP, Desaire H, Bonsignori M, Hwang KK, Beck C, Kakalis M, O'Connell RJ, Vasan S, Kim JH, Michael NL, Excler JL, Robb ML, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Nitayaphan S, Sinangil F, Tartaglia J, Phogat S, Wiehe K, Saunders KO, Montefiori DC, Tomaras GD, Moody MA, Arthos J, Rao M, Joyce MG, Ofek G, Ferrari G, Haynes BF |
| Title | HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. | |
| Journal Name | JCI Insight | |
| Month / Year | 01/2021 | |
| No.1274 | Author | Yoon IK, Srikiatkhachorn A, Alera MT, Fernandez S, Cummings DAT, Salje H |
| Title | Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort. | |
| Journal Name | Int J Infect Dis | |
| Month / Year | 01/2021 | |
| No.1273 | Author | Cavalcante JR, Abreu AJL |
| Title | COVID-19 in the city of Rio de Janeiro: spatial analysis of first confirmed cases and deaths. | |
| Journal Name | Epidemiol Serv Saude | |
| Month / Year | 01/2021 | |
| No.1272 | Author | Krumkamp R, Struck NS, Lorenz E, Zimmermann M, Boahen KG, Sarpong N, Owusu-Dabo E, Pak GD, Jeon HJ, Marks F, Jacobs T, May J, Eibach D |
| Title | Classification of invasive bloodstream infections and Plasmodium falciparum malaria using autoantibodies as biomarkers. | |
| Journal Name | Sci Rep | |
| Month / Year | 01/2021 | |
| No.1271 | Author | Choi JA, Goo J, Yang E, Jung DI, Lee S, Rho S, Jeong Y, Park YS, Park H, Moon YH, Park U, Seo SH, Lee H, Lee JM, Cho NH, Song M, Kim JO |
| Title | Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein. | |
| Journal Name | J Virol | |
| Month / Year | 01/2021 | |
| No.1270 | Author | Kim JH |
| Title | SARS-CoV-2 vaccine development, access, and equity. | |
| Journal Name | J Exp Med | |
| Month / Year | 01/2021 | |
| No.1269 | Author | Manandhar S, Zellweger RM, Maharjan N, Dongol S, Prajapati KG, Thwaites G, Basnyat B, Dixit SM, Baker S, Karkey A |
| Title | A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes. | |
| Journal Name | Ann Clin Microbiol Antimicrob | |
| Month / Year | 01/2021 | |
| No.1268 | Author | Volkmann A, Williamson AL, Weidenthaler H, Meyer TPH, Robertson JS, Excler JL, Condit RC, Evans E, Smith ER, Kim D, Chen RT |
| Title | The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. | |
| Journal Name | Vaccine | |
| Month / Year | 01/2021 | |
| No.1267 | Author | Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S |
| Title | Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. | |
| Journal Name | Vaccine | |
| Month / Year | 01/2021 | |
| No.1266 | Author | Kim JS, Choi JA, Kim JC, Park H, Yang E, Park JS, Song M, Park JH |
| Title | Microneedles with dual release pattern for improved immunological efficacy of Hepatitis B vaccine. | |
| Journal Name | Int J Pharm | |
| Month / Year | 01/2021 | |
| No.1265 | Author | Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS |
| Title | A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report. | |
| Journal Name | BMC Pediatr | |
| Month / Year | 01/2021 | |
| No.1264 | Author | Im J, Islam MT, Ahmmed F, Kim DR, Khan AI, Zaman K, Ali M, Marks F, Qadri F, Kim J, Clemens JD |
| Title | Can existing improvements of water, sanitation, and hygiene (WASH) in urban slums reduce the burden of typhoid fever in these settings? | |
| Journal Name | Clin Infect Dis | |
| Month / Year | 01/2021 | |
| No.1263 | Author | Capeding MR, Sil A, Tadesse BT, Saluja T, Teshome S, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ryu JH, Cheong I, Shim KY, Lee Y, Kim H, Lynch JA, Kim JH, Excler JL, Wartel TA, Sahastrabuddhe S |
| Title | Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study. | |
| Journal Name | EClinicalMedicine | |
| Month / Year | 01/2021 |
